Ligand validation:6DJ2

AB1: N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE

AB1 is a Ligand Of Interest in 6DJ2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6DJ2_AB1_B_201	89%	28%	0.069	0.946	1.59	1.3	4	6	4	0	100%	1
6DJ1_AB1_B_201	88%	35%	0.085	0.961	1.6	0.99	5	2	3	0	100%	0.75
2Z54_AB1_A_200	58%	57%	0.17	0.949	0.56	1.1	-	7	8	0	100%	0.5
2QHC_AB1_B_9001	53%	54%	0.194	0.955	0.59	1.17	-	6	4	0	100%	0.5
2Q5K_AB1_A_201	38%	60%	0.18	0.882	0.45	1.08	-	3	0	0	100%	1
3OGQ_AB1_A_200	67%	28%	0.132	0.941	1	1.88	3	17	7	0	100%	0.5
2RKF_AB1_A_501	60%	53%	0.145	0.931	0.5	1.28	-	4	2	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.